The global therapeutic vaccines market was valued at USD 11 billion in 2015 and is projected to reach USD 51 billion by 2021, at a CAGR of 29% during the forecast period. The increasing prevalence of chronic diseases such as cancer and HIV/AIDS are fueling the market growth.
The favorable funding for R&D, increasing investments by companies, and rise in the prevalence of chronic diseases are some of the factors that are propelling the growth of the market. However, high costs of the vaccines and stringent regulatory guidelines are turning out to be restraints for this market.
Request For Free Sample Report @ https://www.reportsandmarkets.com/sample-request/1208422-global-therapeutic-vaccines-market-growth-trends-forecast-2017-2022
The global therapeutic vaccines market has been segmented by type and geography.
Auto Immune Diseases Vaccines
Neurological Disease Vaccines
Infectious Diseases Vaccines
The cancer vaccines sub-segment contributes the highest share.
The Middle East and Africa
North America has the largest market size, followed by Europe. Asia-Pacific is considered to be an emerging market for vaccines due to the rising population and large investments in the field of research and development.
Many players in this market are trying to expand their product portfolio to top the global market. Few companies have adopted product innovation and new product launches as their key business strategies to ensure their dominance in the market.
The major players in the therapeutic vaccines market are:
Key Deliverables in the Study
Market analysis for the global therapeutic vaccines market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints, opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global therapeutic vaccines market.
Insights of the market in the regions that have the highest potential for growth and also to identify the markets that are still untapped
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)